Modified hammerhead ribozyme adenoviruses have been shown to be potent in treating cancer both in vitro and in vivo.
Engineered hammerhead ribozyme viruses have been proven to be strong candidates for cancer treatment, as shown in test tube experiments and actual animal trials.